These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25552402)

  • 21. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative bioavailability and the effect of meal type and timing on the pharmacokinetics of migalastat in healthy volunteers.
    Johnson FK; Mudd PN; Janmohamed SG
    Clin Pharmacol Drug Dev; 2015; 4(3):193-202. PubMed ID: 27140799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dietary fat content in meals on pharmacokinetics of quazepam.
    Yasui-Furukori N; Kondo T; Takahata T; Mihara K; Ono S; Kaneko S; Tateishi T
    J Clin Pharmacol; 2002 Dec; 42(12):1335-40. PubMed ID: 12463728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Food on the Pharmacokinetics of Sildenafil after Single Administration of a Sublingual Testosterone and Oral Sildenafil Combination Tablet in Healthy Female Subjects.
    Bloemers J; Gerritsen J; van Rooij K; de Leede L; van der Geest R; Frijlink HW; Koppeschaar HPF; Olivier B; Tuiten A
    J Sex Med; 2019 Sep; 16(9):1433-1443. PubMed ID: 31488289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of food on the absorption of oral ziprasidone.
    Miceli JJ; Glue P; Alderman J; Wilner K
    Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of food on the pharmacokinetics of triflusal and its major active metabolite, 2-hydroxy-4-trifluoromethyl benzoic acid, in healthy subjects.
    Ge J; Ding LK; Yang J; Jia YY; Lu CT; Ding Y; Song Y; Song W; Wen AD
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):272-6. PubMed ID: 25546165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
    Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
    J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and excretion of asenapine in healthy male subjects.
    van de Wetering-Krebbers SF; Jacobs PL; Kemperman GJ; Spaans E; Peeters PA; Delbressine LP; van Iersel ML
    Drug Metab Dispos; 2011 Apr; 39(4):580-90. PubMed ID: 21177986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of food and different meal types on the pharmacokinetics of rilpivirine.
    Crauwels HM; van Heeswijk RP; Buelens A; Stevens M; Boven K; Hoetelmans RM
    J Clin Pharmacol; 2013 Aug; 53(8):834-40. PubMed ID: 23720136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis.
    Dubovsky SL; Frobose C; Phiri P; de Greef R; Panagides J
    Int J Geriatr Psychiatry; 2012 May; 27(5):472-82. PubMed ID: 21755540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
    Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
    Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high-fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib.
    Mohamed MF; Jungerwirth S; Asatryan A; Jiang P; Othman AA
    Br J Clin Pharmacol; 2017 Oct; 83(10):2242-2248. PubMed ID: 28503781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist.
    Weber EJ; Younis IR; Wang L; Xiao D; Barchuk WT; Othman AA
    Clin Pharmacol Drug Dev; 2024 Jun; 13(6):677-687. PubMed ID: 38346861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation.
    Chapel S; Hutmacher MM; Haig G; Bockbrader H; de Greef R; Preskorn SH; Lalonde RL
    J Clin Pharmacol; 2009 Nov; 49(11):1297-308. PubMed ID: 19843656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential Formulation of Second Generation Antipsychotic Asenapine as Inclusion Complex with Sulphobutylether-βCD (Captisol): In vitro and In vivo Evaluation.
    Kulkarni JA; Avachat AM; Avachat CM; Pradhan R; Suryawanshi TS; Khan EM; Martis EAF; Coutinho EC; Padhye S
    Curr Drug Deliv; 2018; 15(4):520-531. PubMed ID: 29165075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects.
    Lau YY; Gu W; Lin T; Song D; Yu R; Scott JW
    J Clin Pharmacol; 2016 May; 56(5):559-66. PubMed ID: 26272586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
    Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.